Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series-Reference-Cited by-同舟云学术

Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series

Published:2019-07-25 Issue:5 Volume:181 Page:1072-1074
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Armario‐Hita J.C.¹^ORCID,Pereyra‐Rodriguez J.²,Silvestre J.F.³,Ruiz‐Villaverde R.⁴^ORCID,Valero A.,Izu‐Belloso R.,Jáuregui‐Presa I.,Curto‐Barredo L.^ORCID,Figueras‐Nart I.,Herranz‐Pinto P.,Herraez‐Herrera L.,Ortiz‐de‐Frutos F.J.,Martinez‐Pilar L.,Sastre J.^ORCID,Serra‐Baldrich E.

Affiliation:

1. Department of Dermatology Hospital Universitario Puerto Real Cádiz Spain

2. Department of Dermatology Hospital Universitario Virgen del Rocío Sevilla Spain

3. Department of Dermatology Hospital General de Alicante Alicante Spain

4. Department of Dermatology Hospital Universitario Parque Tecnológico de la Salud Granada Spain

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18041

Reference8 articles.

1. Impacto económico de la dermatitis atópica en adultos: estudio de base poblacional (estudio IDEA)

2. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

3. Atopic Dermatitis in Adults: A Diagnostic Challenge

4. Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders

5. Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin antagonists for atopic dermatitis: a new era of therapy;Expert Opinion on Investigational Drugs;2024-06-02

2. Considerations for managing elderly patients with atopic dermatitis;Expert Review of Clinical Immunology;2024-01-09

3. Safety and efficacy of dupilumab in adult atopic dermatitis in Singapore;Singapore Medical Journal;2024-01-08

4. An Observational Study of Early Treatment Response and Predictors of Dupilumab in the Treatment of Moderate‐to‐Severe Atopic Dermatitis;Dermatologic Therapy;2024-01

5. Updated Review on Treatment of Atopic Dermatitis;Journal of Investigational Allergy and Clinical Immunology;2023-06-15